win jilibet online games GameStop Discloses Third Quarter 2024 ResultsBody is found at a Kingsholme park in a grim discoveryMarket Movements You Can’t Ignore: What’s Happening with TSM?

Nikolas Ibey viewed dozens of victim's Facebook photos before killing herAllegion PLC stock rises Monday, outperforms market

NoneNonePAY ATTENTION: Follow our WhatsApp channel to never miss out on the news that matters to you! Outgoing US President Joe Biden on Tuesday branded his successor Donald Trump's economic plans a "disaster," in a speech hailing his own legacy. Biden said Trump's threats to slap huge tariffs on imports were a "major mistake" and challenged Trump to build on what he said were the successes of his own administration. The lame-duck president's speech comes after Trump won a second term largely on the back of US voters' anger at high costs of living under Democrats. "I pray to God the president-elect throws away Project 2025. I think it'd be an economic disaster for us and the region," Biden said at the Brookings Institution in Washington, referring to a conservative blueprint for a second Trump administration. Coughing frequently because of a cold, Biden said US consumers would pay the price for the tariffs that Trump has vowed to slap on US neighbors Mexico and Canada and on Asia-Pacific rival China. Read also Most markets down as traders assess crises in S.Korea, France Together they are the three biggest US trading partners. PAY ATTENTION: Follow us on Instagram - get the most important news directly in your favourite app! "I believe this approach is a major mistake," Biden added. At a separate event Tuesday, Treasury Secretary Janet Yellen said Trump's tariffs could "derail the progress that we've made on inflation, and have adverse consequences on growth." She warned at the Wall Street Journal's CEO Council Summit that sweeping tariffs could raise prices significantly for US consumers and pile pressure on companies which rely on imports. Shadow president The White House touted Biden's speech as a "major address on his economic legacy" as the 82-year-old looks to the history books with fewer than six weeks left in office. Biden dropped out of the 2024 presidential race against Trump in July due to concerns about his age and passed the torch to Vice President Kamala Harris, whom Trump comfortably defeated at the November polls. Trump's inauguration is not until January 20, but he has already become something of a shadow president, making pronouncements on the economy and foreign policy and being feted by world leaders. Read also South Korea stocks drop, won stable as Asian markets fluctuate Biden has kept a relatively low profile, but he came out swinging in defense of his own record before an audience of economists. He contrasted his "middle-out, bottom-up economic playbook" with what he called Trump's failed promise of "trickle-down economics" in which tax cuts for the wealthy are supposed to boost incomes. Biden also touted achievements including the US economy's recovery from the Covid pandemic and his huge investments in green technology and industry. "President-elect Trump is receiving the strongest economy in modern history," said Biden. But the departing president said he regretted not signing his name to Covid stimulus checks sent out to Americans, like Trump had done. Biden ended his speech with a broader plea for US leadership in a troubled world, even as Trump has repeatedly signaled his intention to take a more isolationist stance. "If we do not lead the world, what nation leads the world?" he said. PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy! Source: AFP

MASON COUNTY, MI -- A Ludington teen was left injured and another arrested after a stabbing in an alley near downtown. Police were called around 7:37 p.m., Friday, Nov. 22, to the Legacy Plaza in downtown Ludington for a report of a stabbing, Ludington police said in a release on social media. When they arrived, police found a 16-year-old boy with a stab wound to his lower back.CEVA, Inc. (NASDAQ:CEVA) Stake Lifted by Connor Clark & Lunn Investment Management Ltd.The team that President-elect Donald Trump has selected to lead federal health agencies in his second administration includes a retired congressman, a surgeon and a former talk-show host. All could play pivotal roles in fulfilling a political agenda that could change how the government goes about safeguarding Americans' health — from health care and medicines to food safety and science research. In line to lead the Department of Health and Human Services secretary is environmental lawyer and anti-vaccine organizer Robert F. Kennedy Jr. Trump's choices don't have experience running large bureaucratic agencies, but they know how to talk about health on TV . Centers for Medicare and Medicaid pick Dr. Mehmet Oz hosted a talk show for 13 years and is a well-known wellness and lifestyle influencer. The pick for the Food and Drug Administration, Dr. Marty Makary, and for surgeon general, Dr. Janette Nesheiwat, are frequent Fox News contributors. Many on the list were critical of COVID-19 measures like masking and booster vaccinations for young people. Some of them have ties to Florida like many of Trump's other Cabinet nominees: Dave Weldon , the pick for the Centers for Disease Control and Prevention, represented the state in Congress for 14 years and is affiliated with a medical group on the state's Atlantic coast. Nesheiwat's brother-in-law is Rep. Mike Waltz , R-Fla., tapped by Trump as national security adviser. Here's a look at the nominees' potential role in carrying out what Kennedy says is the task to “reorganize” agencies, which have an overall $1.7 trillion budget, employ 80,000 scientists, researchers, doctors and other officials, and effect Americans' daily lives: The Atlanta-based CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. Kennedy has long attacked vaccines and criticized the CDC, repeatedly alleging corruption at the agency. He said on a 2023 podcast that there is "no vaccine that is safe and effective,” and urged people to resist the CDC's guidelines about if and when kids should get vaccinated . The World Health Organization estimates that vaccines have saved more than 150 million lives over the past 50 years, and that 100 million of them were infants. Decades ago, Kennedy found common ground with Weldon , 71, who served in the Army and worked as an internal medicine doctor before he represented a central Florida congressional district from 1995 to 2009. Starting in the early 2000s, Weldon had a prominent part in a debate about whether there was a relationship between a vaccine preservative called thimerosal and autism. He was a founding member of the Congressional Autism Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior attorney for the Natural Resources Defense Council, believed there was a tie between thimerosal and autism and also charged that the government hid documents showing the danger. Since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Meanwhile, study after study after study found no evidence that thimerosal caused autism. Weldon's congressional voting record suggests he may go along with Republican efforts to downsize the CDC, including to eliminate the National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses and shooting deaths. Weldon also voted to ban federal funding for needle-exchange programs as an approach to reduce overdoses, and the National Rifle Association gave him an “A” rating for his pro-gun rights voting record. Kennedy is extremely critical of the FDA, which has 18,000 employees and is responsible for the safety and effectiveness of prescription drugs, vaccines and other medical products, as well as overseeing cosmetics, electronic cigarettes and most foods. Makary, Trump’s pick to run the FDA, is closely aligned with Kennedy on several topics . The professor at Johns Hopkins University who is a trained surgeon and cancer specialist has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators. Kennedy has suggested he'll clear out “entire” FDA departments and also recently threatened to fire FDA employees for “aggressive suppression” of a host of unsubstantiated products and therapies, including stem cells, raw milk , psychedelics and discredited COVID-era treatments like ivermectin and hydroxychloroquine. Makary's contrarian views during the COVID-19 pandemic included questioning the need for masking and giving young kids COVID-19 vaccine boosters. But anything Makary and Kennedy might want to do when it comes to unwinding FDA regulations or revoking long-standing vaccine and drug approvals would be challenging. The agency has lengthy requirements for removing medicines from the market, which are based on federal laws passed by Congress. The agency provides health care coverage for more than 160 million people through Medicaid, Medicare and the Affordable Care Act, and also sets Medicare payment rates for hospitals, doctors and other providers. With a $1.1 trillion budget and more than 6,000 employees, Oz has a massive agency to run if confirmed — and an agency that Kennedy hasn't talked about much when it comes to his plans. While Trump tried to scrap the Affordable Care Act in his first term, Kennedy has not taken aim at it yet. But he has been critical of Medicaid and Medicare for covering expensive weight-loss drugs — though they're not widely covered by either . Trump said during his campaign that he would protect Medicare, which provides insurance for older Americans. Oz has endorsed expanding Medicare Advantage — a privately run version of Medicare that is popular but also a source of widespread fraud — in an AARP questionnaire during his failed 2022 bid for a U.S. Senate seat in Pennsylvania and in a 2020 Forbes op-ed with a former Kaiser Permanente CEO. Oz also said in a Washington Examiner op-ed with three co-writers that aging healthier and living longer could help fix the U.S. budget deficit because people would work longer and add more to the gross domestic product. Neither Trump nor Kennedy have said much about Medicaid, the insurance program for low-income Americans. Trump's first administration reshaped the program by allowing states to introduce work requirements for recipients. Kennedy doesn't appear to have said much publicly about what he'd like to see from surgeon general position, which is the nation's top doctor and oversees 6,000 U.S. Public Health Service Corps members. The surgeon general has little administrative power, but can be an influential government spokesperson on what counts as a public health danger and what to do about it — suggesting things like warning labels for products and issuing advisories. The current surgeon general, Vivek Murthy, declared gun violence as a public health crisis in June. Trump's pick, Nesheiwat, is employed as a New York City medical director with CityMD, a group of urgent care facilities in the New York and New Jersey area, and has been at City MD for 12 years. She also has appeared on Fox News and other TV shows, authored a book on the “transformative power of prayer” in her medical career and endorses a brand of vitamin supplements. She encouraged COVID-19 vaccines during the pandemic, calling them “a gift from God” in a February 2021 Fox News op-ed, as well as anti-viral pills like Paxlovid. In a 2019 Q&A with the Women in Medicine Legacy Foundation , Nesheiwat said she is a “firm believer in preventive medicine” and “can give a dissertation on hand-washing alone.” As of Saturday, Trump had not yet named his choice to lead the National Institutes of Health, which funds medical research through grants to researchers across the nation and conducts its own research. It has a $48 billion budget. Kennedy has said he'd pause drug development and infectious disease research to shift the focus to chronic diseases. He'd like to keep NIH funding from researchers with conflicts of interest, and criticized the agency in 2017 for what he said was not doing enough research into the role of vaccines in autism — an idea that has long been debunked . Associated Press writers Amanda Seitz and Matt Perrone and AP editor Erica Hunzinger contributed to this report. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. This story has been corrected to reflect that the health agencies have an overall budget of about $1.7 trillion, not $1.7 billion. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Sign up here to get the latest health & fitness updates in your inbox every week!

At the crossroads of news and opinion, ‘Morning Joe’ hosts grapple with aftermath of Trump meeting

TORONTO , Nov. 22, 2024 /CNW/ - Franklin Templeton Canada today announced cash distributions for certain ETFs and ETF series of mutual funds available to Canadian investors. As detailed in the table below, unitholders of record as of November 29, 2024 , will receive a per-unit cash distribution payable on December 9, 2024 . Fund Name Ticker Type Cash Distribution Per Unit ($) Payment Frequency Franklin Brandywine Global Sustainable Income Optimiser Fund – ETF Series FBGO Active 0.090153 Monthly Franklin ClearBridge Sustainable Global Infrastructure Income Fund – ETF Series FCII Active 0.011902 Monthly Franklin Canadian Government Bond Fund – ETF Series FGOV Active 0.049478 Monthly Franklin Canadian Ultra Short Term Bond Fund – ETF Series FHIS Active 0.066623 Monthly Franklin Canadian Corporate Bond Fund – ETF Series FLCI Active 0.066540 Monthly Franklin Canadian Core Plus Bond Fund – ETF Series FLCP Active 0.049906 Monthly Franklin Global Core Bond Fund – ETF Series FLGA Active 0.036584 Monthly Franklin Canadian Short Term Bond Fund – ETF Series FLSD Active 0.061568 Monthly Franklin Canadian Low Volatility High Dividend Index ETF FLVC Passive 0.056133 Monthly Franklin International Low Volatility High Dividend Index ETF FLVI Passive 0.068600 Monthly Franklin U.S. Low Volatility High Dividend Index ETF FLVU Passive 0.037867 Monthly Estimated Annual Reinvested Distributions Unitholders of record on December 31, 2024, will receive a per-unit reinvested distribution payable on January 9, 2025. These annual reinvested distributions, detailed in the table below, are estimates only as of September 30, 2024. The final year-end distribution amounts will be announced on December 20, 2024. Fund Name Ticker Type Estimated Annual Reinvested Distribution Per Unit ($) Franklin Core ETF Portfolio – ETF Series CBL Active 0.345380 Franklin Conservative Income ETF Portfolio – ETF Series CNV Active - Franklin All-Equity ETF Portfolio – ETF Series EQY Active 0.068630 Franklin Brandywine Global Sustainable Income Optimiser Fund – ETF Series FBGO Active - Franklin ClearBridge Sustainable Global Infrastructure Income Fund – ETF Series FCII Active - Franklin ClearBridge Sustainable International Growth Fund – ETF Series FCSI Active - Franklin Global Growth Fund – ETF Series FGGE Active - Franklin Canadian Government Bond Fund – ETF Series FGOV Active - Franklin Canadian Ultra Short Term Bond Fund – ETF Series FHIS Active - Franklin Innovation Fund – ETF Series FINO Active - Franklin FTSE U.S. Index ETF FLAM Passive 0.158483 Franklin FTSE Canada All Cap Index ETF FLCD Passive - Franklin Canadian Corporate Bond Fund – ETF Series FLCI Active - Franklin Canadian Core Plus Bond Fund – ETF Series FLCP Active - Franklin Emerging Markets Equity Index ETF FLEM Passive - Franklin Global Core Bond Fund – ETF Series FLGA Active - Franklin FTSE Japan Index ETF FLJA Passive - Franklin Canadian Short Term Bond Fund – ETF Series FLSD Active - Franklin International Equity Index ETF FLUR Passive 0.029145 Franklin U.S. Large Cap Multifactor Index ETF FLUS Smart Beta 2.299712 Franklin Canadian Low Volatility High Dividend Index ETF FLVC Passive 0.127420 Franklin International Low Volatility High Dividend Index ETF FLVI Passive 0.287091 Franklin U.S. Low Volatility High Dividend Index ETF FLVU Passive 0.040207 Franklin Growth ETF Portfolio – ETF Series GRO Active 0.598660 The annual reinvested distributions, as applicable, will not be paid in cash but reinvested in additional units and reported as taxable distributions, with a corresponding increase in each unitholder's adjusted cost base of their units of the respective ETF. The additional ETF units will be immediately consolidated so that the number of units held by the unitholder, the outstanding units and the net asset value of the ETFs will not change as a result of the annual reinvested distribution. The annual reinvested distributions, as applicable, are expected to be capital gains in nature for each of the ETFs. The actual taxable amounts of cash and reinvested distributions for 2024, including the tax characteristics of the distributions, will be reported to brokers through CDS Clearing and Depository Services Inc. in early 2025. Franklin Templeton's diverse and innovative ETF platform was built to provide better client outcomes for a range of market conditions and investment opportunities. The product suite offers active, smart beta and passive ETFs that span multiple asset classes and geographies. For more information, please visit franklintempleton.ca/etf . About Franklin Templeton Franklin Resources, Inc. BEN is a global investment management organization with subsidiaries operating as Franklin Templeton and serving clients in over 150 countries. In Canada, the company's subsidiary is Franklin Templeton Investments Corp., which operates as Franklin Templeton Canada . Franklin Templeton's mission is to help clients achieve better outcomes through investment management expertise, wealth management and technology solutions. Through its specialist investment managers, the company offers specialization on a global scale, bringing extensive capabilities in fixed income, equity, alternatives and multi-asset solutions. With more than 1,500 investment professionals, and offices in major financial markets around the world, the California -based company has over 75 years of investment experience and over US$1.6 trillion (over CAN$2.2 trillion) in assets under management as of October 31, 2024. For more information, please visit franklintempleton.ca . Commissions, management fees and expenses all may be associated with investments in ETFs and ETF series. Investors should carefully consider an ETF's and ETF series' investment objectives and strategies, risks, fees and expenses before investing. The prospectus and ETF facts contain this and other information. Please read the prospectus and ETF facts carefully before investing. ETFs and ETF series trade like stocks, fluctuate in market value and may trade at prices above or below their net asset value. Brokerage commissions and ETF and ETF series expenses will reduce returns. ETFs and ETF series are not guaranteed, their values change frequently, and past performance may not be repeated. Copyright © 2024. Franklin Templeton. All rights reserved. SOURCE Franklin Templeton Investments Corp. View original content: http://www.newswire.ca/en/releases/archive/November2024/22/c5240.html © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Lawyers for a voting machine company that’s suing Fox News want to question founder Rupert Murdoch about his contentious efforts to change his family trust , the attorneys told a court Monday. Election-tech company Smartmatic's $2.7 billion defamation suit regards Fox's reporting on 2020 voting fraud claims. But Smartmatic’s attorneys suggest the separate succession fight over Murdoch's media empire might shed light on any Fox Corp. involvement in editorial matters. It's an important, if technical, question as Smartmatic seeks to hold the deep-pocketed Fox parent company responsible for statements that the news network aired. Fox contends that there's no such liability and that it was engaging in journalism, not defamation, when it broadcast election-fraud allegations made by then-President Donald Trump 's attorneys. Rupert Murdoch may already have given a deposition — out-of-court questioning under oath — in the defamation suit. Such records aren't public at this stage, but plans for his deposition were briefly mentioned at a 2022 hearing. Smartmatic now is seeking to talk to Murdoch about his efforts to rewrite his plans for his businesses after his death. The matter is playing out behind closed doors and in sealed files in a Nevada probate court. The New York Times has reported that Rupert Murdoch wants to keep his eldest son, Lachlan , in charge of the conglomerate's newspapers and television networks in order to ensure a continued conservative editorial outlook . Smartmatic wants to get the 93-year-old patriarch on record while the probate matter plays out, company attorney Edward Wipper told a judge Monday. Fox News lawyer K. Winn Allen said the probate case “has nothing at all to do with” Smartmatic's claims and is “not appropriate” fodder for the suit. Fox Corp. declined to comment after court. Fox News' lawyers, meanwhile, want Smartmatic to provide records about a U.S. federal criminal case against people, including Smartmatic co-founder Roger Piñate, accused of scheming to bribe a Filipino election official . Piñate has pleaded not guilty. Smartmatic isn't charged in the criminal case, and Smartmatic attorneys have said the matter was irrelevant to the defamation suit. Fox lost prior bids for a court order to get the information, but a hearing on the network's renewed request is set next week. It's unclear how soon Judge David B. Cohen will decide on that request or on Smartmatic's bid to dig into the Murdoch family trust case. Both requests are part of pretrial information-gathering, and no trial date has been set. Smartmatic says it was a small player, working only with California's heavily Democratic Los Angeles County, in the 2020 U.S. presidential election. In subsequent Fox News appearances, Trump lawyers Rudy Giuliani and Sidney Powell portrayed Smartmatic as part of a multi-state scheme to steal the vote from the Republican. Federal and state election officials , exhaustive reviews in battleground states and Trump’s own attorney general found no widespread fraud that could have changed the outcome of the 2020 election. Nor did they uncover any credible evidence that the vote was tainted. Dozens of courts, including by judges whom Trump had appointed, rejected his fraud claims. Fox News ultimately aired an interview with an election technology expert who refuted the allegations against Smartmatic — an interview done after the company demanded a retraction . The network is countersuing Smartmatic , claiming it violated a New York law against baseless suits aimed at squelching reporting or criticism on public issues. The New York defamation suit is one of several stemming from conservative-oriented news outlets' reports on Trump’s 2020 vote-rigging claims. Smartmatic recently settled with One America News Network and Newsmax . Fox News settled for $787 million last year with Dominion Voting Systems, another election-technology company that sued over conspiracy theories blaming its election equipment for Trump’s 2020 loss.